Target intelligence / Profile preview

Other cellular proteins with nucleophilic residues

Molecular classification
Other
01

Overview

Other cellular proteins with nucleophilic residues is a descriptive category rather than a specific biological target. It encompasses a wide variety of proteins that possess reactive functional groups, such as the thiol group of cysteine or the amino group of lysine, which can react with electrophilic molecules (Sutcliffe et al., 2011, PMC3136715). In pharmacology, this term is frequently used to describe the sites of off-target covalent binding for drugs designed as covalent inhibitors (Singh et al., 2011, Nature Reviews Drug Discovery). While the primary therapeutic effect of such drugs comes from binding to a specific protein, non-selective interaction with these other proteins can lead to the formation of protein-drug adducts (Liebler, 2008, Chemical Research in Toxicology). These adducts are often associated with toxicological outcomes, including cellular dysfunction and the induction of immune responses (Park et al., 2005, PubMed 15922018). Specifically, the modification of off-target proteins can create haptens that trigger idiosyncratic drug reactions, posing a significant challenge for drug safety (Uetrecht, 2007, PubMed 17907110). Therefore, characterizing these nucleophilic residues is essential for minimizing toxicity during the development of electrophilic medicinal chemistry.

Other names
Nucleophilic protein residuesCovalent off-targetsReactive protein side chainsNucleophilic amino acid residues
02

Mechanism of action

Covalent modification of nucleophilic amino acid side chains (e.g., cysteine, lysine, serine) via electrophilic attack, resulting in the formation of stable protein-drug adducts.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Off-target toxicityHapten formationIdiosyncratic drug reactionsImmunogenicityOrgan toxicity
06

Interacting drugs

Aspirin

5 more in the full profile.

07

Biomarkers

Protein-drug adductsGlutathione depletion

Beyond the preview

Go deeper on Other cellular proteins with nucleophilic residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other cellular proteins with nucleophilic residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call